GEHC

GE HealthCare Technologies Inc.

83.00

Top Statistics
Market Cap 37 B Forward PE 17.77 Revenue Growth 0.90 %
Current Ratio 1.23 Trailing PE 22.74 Earnings Growth 24.20 %
Profit Margins 8.56 % Peg Ratio Dividend Yield 0.17 %
Enterprice / EBITA 12.69 Enterprise / Revenue 2.32 Price To Sales Trailing12 Months 1.94
Profitability
Profit Margins 8.56 % Operating Margins 16.06 %
Balance Sheet
Total Cash 3 B Total Cash Per Share 7.77 Total Debt 10 B
Total Debt To Equity 126.09 Current Ratio 1.23 Book Value Per Share 18.20
All Measures
Short Ratio 281.00 % Message Board Id finmb_1804385326 Shares Short Prior Month 9 M
Return On Equity 0.2185 City Chicago Uuid 5049484e-cf95-3e3c-a4f5-8fcbdec47bf1
Previous Close 82.51 First Trade Date Epoch Utc 1 B Book Value 18.20
Total Debt 10 B Volume 1 M Price To Book 4.56
Fifty Two Week Low 66.39 Total Cash Per Share 7.77 Total Revenue 19 B
Shares Short Previous Month Date 1 B Target Median Price 97.00 Audit Risk 10
Max Age 86400 Recommendation Mean 1.95 Sand P52 Week Change 0.3133
Operating Margins 16.06 % Last Dividend Value 0.0300 Target Mean Price 96.81
Net Income To Common 1 B Short Percent Of Float 0.0243 Implied Shares Outstanding 456 M
Trailing Peg Ratio 207.17 % Last Fiscal Year End 1 B Average Daily Volume10 Day 3 M
Average Volume10days 3 M Total Cash 3 B Next Fiscal Year End 1 B
Revenue Per Share 42.92 Held Percent Insiders 0.0309 Ebitda Margins 18.26 %
Dividend Rate 0.1400 Trailing PE 22.74 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 5 Regular Market Previous Close 82.51
Target Low Price 74.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 88.07
Open 82.85 Dividend Yield 0.17 % State IL
Free Cashflow 1 B Return On Assets 0.0564 Time Zone Short Name EST
Board Risk 6 Trailing Eps 3.65 Day Low 82.72
Address1 500 West Monroe Street Trailing Annual Dividend Rate 0.1200 Compensation Risk 6
Price Hint 2 Shares Outstanding 456 M Target High Price 110.00
Website https://www.gehealthcare.com 52 Week Change 0.2124 Average Volume 3 M
Earnings Quarterly Growth 25.30 % Forward Eps 4.67 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 88.30 % Is_sp_500 True
Regular Market Day High 83.91 Profit Margins 8.56 % Debt To Equity 126.09
Fifty Two Week High 94.55 Day High 83.91 Shares Short 8 M
Regular Market Open 82.85 Industry Key health-information-services Earnings Growth 24.20 %
Enterprise To Revenue 2.32 Revenue Growth 0.90 % Shares Percent Shares Out 0.0191
Operating Cashflow 2 B Currency USD Time Zone Full Name America/New_York
Market Cap 37 B Is_nasdaq_100 True Zip 60661
Payout Ratio 3.29 % Quote Type EQUITY Industry Health Information Services
Ex Dividend Date 1 B Overall Risk 7 Regular Market Day Low 82.72
Held Percent Institutions 0.8352 Long Name GE HealthCare Technologies Inc. Enterprise To Ebitda 12.69
Current Price 83.00 Trailing Annual Dividend Yield 0.15 % Financial Currency USD
Current Ratio 1.23 Gross Margins 41.34 % Industry Disp Health Information Services
Number Of Analyst Opinions 19 Country United States Float Shares 442 M
Two Hundred Day Average 84.84 Governance Epoch Date 1 B Enterprise Value 45 B
Price To Sales Trailing12 Months 1.94 Forward PE 17.77 Regular Market Volume 1 M
Last Dividend Date 1 B Ebitda 3 B Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.

The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products.

The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products.

The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions.

Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services.

The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry.

The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes.

It has an AI collaboration with Mass General Brigham.

The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022.

The company was incorporated in 2022 and is headquartered in Chicago, Illinois.